NCT00626106 2024-09-19QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast CancerNantCell, Inc.Phase 2 Completed156 enrolled 16 charts